Canadian pharmacy and doctors’ groups, fearing domestic shortages, are pushing their government to make opposing the Trump administration’s drug-importation plan a major focus of the new government.
A coalition of health groups, including the Canadian Medical Association and McKesson Canada, have started a campaign aimed at demanding the Canadian government and the Parliament take measures to block importation projects from states like Florida. They warn allowing wholesale importation of medicines into the U.S. will mean fewer supplies at home.
While Canadian government officials have publicly opposed importation plans and say they can’t help lower U.S. drug costs, America’s neighbor ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.